CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Grant or award · Restricted Share Units | +73,720 | 73,720 | ||
| 2020-02-28 | Schultz Kare President and CEO | Grant or award · Restricted Share Units | +260,190 | 260,190 | ||
| 2020-02-28 | Sabag Mark See "Remarks" below | Grant or award · Restricted Share Units | +82,393 | 82,393 | ||
| 2020-02-28 | O'Grady Brendan P. EVP, North America Commercial | Grant or award · Restricted Share Units | +99,739 | 99,739 | ||
| 2020-02-28 | Nazzi Gianfranco EVP, International Markets | Grant or award · Restricted Share Units | +60,711 | 60,711 | ||
| 2020-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +73,720 | 73,720 | ||
| 2020-02-28 | Griffin Deborah A Chief Accounting Officer | Grant or award · Restricted Share Units | +21,459 | 21,459 | ||
| 2020-02-28 | Fridriksdottir Hafrun Executive VP, Global R&D | Grant or award · Restricted Share Units | +86,730 | 86,730 | ||
| 2020-02-28 | Drape Eric Executive VP Global Operations | Grant or award · Restricted Share Units | +78,057 | 78,057 | ||
| 2020-02-28 | Dethlefs Sven EVP Global Marketing&Portfolio | Grant or award · Restricted Share Units | +69,384 | 69,384 | ||
| 2020-02-28 | Daniell Richard Exec. VP, European Commercial | Grant or award · Restricted Share Units | +82,393 | 82,393 | ||
| 2020-02-19 | Drape Eric Executive VP Global Operations | Sale | −8,000 | $12.51 | $100K | 21,494 |
| 2020-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +13,090 | 16,064.39 | ||
| 2020-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +3,926 | 19,990.39 | ||
| 2020-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −13,090 | $12.14 | $159K | 6,900.39 |
| 2020-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −3,926 | $12.14 | $48K | 2,974.39 |
| 2020-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −13,090 | 0 | ||
| 2020-02-14 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −3,926 | 3,926 | ||
| 2020-02-14 | Sabag Mark See "Remarks" below | Option exercise | +19,040 | 19,040 | ||
| 2020-02-14 | Sabag Mark See "Remarks" below | Option exercise | +5,710 | 24,750 |
Page 58 of 76 · 1,517 trades